These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

131 related articles for article (PubMed ID: 3410489)

  • 1. Hereditary C3 hypocomplementemia in the rabbit.
    Komatsu M; Yamamoto K; Nakano Y; Nakazawa M; Ozawa A; Mikami H; Tomita M; Migita S
    Immunology; 1988 Jul; 64(3):363-8. PubMed ID: 3410489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. An inherited deficiency of the third component of complement, C3, in guinea pigs.
    Burger R; Gordon J; Stevenson G; Ramadori G; Zanker B; Hadding U; Bitter-Suermann D
    Eur J Immunol; 1986 Jan; 16(1):7-11. PubMed ID: 3512275
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Genetic deficiency of the alpha-gamma-subunit of the eighth complement component in the rabbit.
    Komatsu M; Yamamoto K; Kawashima T; Migita S
    J Immunol; 1985 Apr; 134(4):2607-9. PubMed ID: 3973389
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study on C3-like factor in the serum of a C3-deficient subject.
    Kitamura H; Nishimukai H; Sano Y; Nagaki K
    Immunology; 1984 Feb; 51(2):239-45. PubMed ID: 6693133
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hereditary C6 deficiency in man.
    Frank MM; Leddy JP; Gaither T; Heusinkveld RS; Breckenridge RT; Klemperer MR
    Birth Defects Orig Artic Ser; 1975; 11(1):318-21. PubMed ID: 807274
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of immune haemolysis by a serum factor found in C3-deficient subjects.
    Kitamura H; Tsuboi M
    Immunology; 1989 Feb; 66(2):264-9. PubMed ID: 2925225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Isolation and identification of the third component of complement of Japanese quails.
    Kai C; Yoshikawa Y; Yamanouchi K; Okada H
    J Immunol; 1983 Jun; 130(6):2814-20. PubMed ID: 6343485
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Which complement assays and typings are necessary for the diagnosis of complement deficiency in patients with lupus erythematosus? A study of 25 patients.
    Boeckler P; Meyer A; Uring-Lambert B; Goetz J; Cribier B; Hauptmann G; Lipsker D
    Clin Immunol; 2006 Nov; 121(2):198-202. PubMed ID: 16987709
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Nonimmunologic complement activation in normal human serum induced by radiographic contrast media.
    Kolb WP; Lang JH; Lasser EC
    J Immunol; 1978 Oct; 121(4):1232-8. PubMed ID: 100552
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of IFN-alpha on total haemolytic activity of CH50 complement system and C3, C4 levels in children with chronic hepatitis C.
    Woźniakowska-Gesicka T; Wiśniewska-Ligier M; Kupś J
    Med Sci Monit; 2001 May; 7 Suppl 1():202-6. PubMed ID: 12211720
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [An exceptional component C3 deficiency revealed by serum protein electrophoresis].
    Dejoie T; Audrain M; Bach-Ngohou K; Denis M; Legoue-Morillon S; Thomas C; Masson D
    Ann Biol Clin (Paris); 2009; 67(6):715-9. PubMed ID: 19939777
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Studies of the acute phase response in experimental serum sickness.
    Martyn P; Charlesworth JA; Peake PW; Pussell BA
    J Clin Lab Immunol; 1990 Feb; 31(2):69-73. PubMed ID: 1966987
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Studies on the mechanism of bacterial resistance to complement-mediated killing. VI. IgG increases the bactericidal efficiency of C5b-9 for E. coli 0111B4 by acting at a step before C5 cleavage.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2570-5. PubMed ID: 6355297
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Studies of the mechanism of bacterial resistance to complement-mediated killing. V. IgG and F(ab')2 mediate killing of E. coli 0111B4 by the alternative complement pathway without increasing C5b-9 deposition.
    Joiner KA; Goldman RC; Hammer CH; Leive L; Frank MM
    J Immunol; 1983 Nov; 131(5):2563-9. PubMed ID: 6355296
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Serum bactericidal activity and phagocytosis in host defence against Haemophilus ducreyi.
    Lagergård T; Frisk A; Purvèn M; Nilsson LA
    Microb Pathog; 1995 Jan; 18(1):37-51. PubMed ID: 7783597
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Human seminal plasma inhibition of complement.
    Petersen BH; Lammel CJ; Stites DP; Brooks GF
    J Lab Clin Med; 1980 Oct; 96(4):582-91. PubMed ID: 6775032
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Studies in vivo and in vitro on an abnormality in the metabolism of C3 in a patient with increased susceptibility to infection.
    Alper CA; Abramson N; Johnston RB; Jandl JH; Rosen FS
    J Clin Invest; 1970 Nov; 49(11):1975-85. PubMed ID: 4097977
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Monoclonal antibodies directed against gonococcal protein I vary in bactericidal activity.
    Joiner KA; Warren KA; Tam M; Frank MM
    J Immunol; 1985 May; 134(5):3411-9. PubMed ID: 3920319
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Differential functional expression of the C8 subunits. Primary role of C8 beta in assembly of intact C8.
    Densen P; McRill CM
    J Immunol; 1988 Oct; 141(8):2674-9. PubMed ID: 3171181
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Serum haemolytic activity, C3 levels and electrophoretic changes in C3 levels in normal human sera stored at 4 degrees C.
    Yemul VL; Jad CY; Kelkar SS
    J Postgrad Med; 1983 Apr; 29(2):100-4. PubMed ID: 6631756
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.